The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 36 | 28.0x | 20.1x | Near average | |
Growth | 69 | 24.2% | 5.6% | Above average | |
Quality | 74 | 767.4% | 7.6% | Above average | |
Safety | 86 | -0.8x | 0.4x | Above average | |
Capital Return | 54 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Medpace Holdings, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Medpace Holdings, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Medpace stock shows complete stability in the average price target at $498.86 over the past thirty days, with an absence of any recent adjustments by the four analysts covering the stock. The spread between the highest price target ($582) and the lowest ($400) indicates a notable variance in fair value estimates, reflecting uncertainty regarding the company's ability to exceed current expectations in the absence of new valuation catalysts.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.